To illustrate the use and interpretation of the bioinformatics tools and data resources introduced in this review, we present use cases for three proteins that are either established biomarkers or promising candidates for AD: neurogranin, tau and TREM2. This evidence concerns the gene MAPT and Alzheimer disease.